YaoGeJu

Company directoryChina company filings

Beijing Sihuan Kebao Pharmaceutical Co., Ltd.

As of 17 November 2026, for the company name Beijing Sihuan Kebao Pharmaceutical Co., Ltd. as recorded, 8 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 48 records, across 29 drug names; since 21 August 2026, the records list Accepted: 3 applications; the chemical-drug catalogue lists 21 active records with this name as holder; 2 active API registrations list this name as first registered company; 16 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

48 acceptance records as first applicant, grouped into 29 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Cetylpyridinium Chloride Buccal Tablets 1 records · Latest accepted 2026/10/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602521Generic2026/10/13Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
感冒清解颗粒 · No verified English name 1 records · Latest accepted 2026/09/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2604923Supplement2026/09/23Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
杏灵分散片 · No verified English name 2 records · Latest accepted 2026/08/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2604298Supplement2026/08/24Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYZB2402144Supplement2024/11/01Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets 4 records · Latest accepted 2026/08/12

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601983Generic2026/08/12Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2601982Generic2026/08/12Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2501681Generic2025/05/09Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2501680Generic2025/05/09Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
注射用葛根素 · No verified English name 3 records · Latest accepted 2026/06/11

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601100Supplement2026/06/11Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2601099Supplement2026/06/11Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2601098Supplement2026/06/11Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Bosentan Tablets 2 records · Latest accepted 2025/10/10

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501974Supplement2025/10/10Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHS2300826Generic2023/03/17Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Lornoxicam for Injection 1 records · Latest accepted 2025/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503203Generic2025/08/30Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2025/04/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501602Generic2025/04/29Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) 1 records · Latest accepted 2025/04/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501603Generic2025/04/29Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Fluvastatin Sodium Extended Release Tablets 1 records · Latest accepted 2025/02/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500859Generic2025/02/27Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Piracetam Injection 2 records · Latest accepted 2025/01/22

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500406Generic2025/01/22Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHS2302943Generic2023/10/31Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Azithromycin for Suspension 1 records · Latest accepted 2024/09/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403308Generic2024/09/30Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Ambroxol Hydrochloride Oral Solution 4 records · Latest accepted 2024/09/19

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403121Generic2024/09/19Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2403120Generic2024/09/19Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2403119Generic2024/09/19Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2403118Generic2024/09/19Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
Cetitizine Hydrochloride Oral Solution 2 records · Latest accepted 2024/07/25

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402340Generic2024/07/25Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2402339Generic2024/07/25Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
依巴斯汀片 · No verified English name 1 records · Latest accepted 2024/07/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402052Generic2024/07/06Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
地氯雷他定口服溶液 · No verified English name 3 records · Latest accepted 2024/07/04

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402009Generic2024/07/04Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2402008Generic2024/07/04Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2402007Generic2024/07/04Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
Nicorandil Tablets 1 records · Latest accepted 2024/03/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400774Generic2024/03/06Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Bilastine Tablets 1 records · Latest accepted 2024/02/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400460Generic2024/02/03Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Nicorandil for Injection 3 records · Latest accepted 2023/09/06

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301996Supplement2023/09/06Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2250167Supplement2022/03/17Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2250166Supplement2022/03/17Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Pentoxifylline Injection 1 records · Latest accepted 2023/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302319Generic2023/08/30Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Felodipine Sustained Release Tablets 2 records · Latest accepted 2023/08/22

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301866Supplement2023/08/22Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2200586Supplement2022/04/06Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Mitiglinide Calcium Tablets 2 records · Latest accepted 2023/05/23

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350449Supplement2023/05/23Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2250677Supplement2022/11/02Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Omeprazole Sodium for Injection 1 records · Latest accepted 2023/01/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350072Supplement2023/01/17Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
注射用尼莫地平 · No verified English name 2 records · Latest accepted 2022/08/23

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201487Supplement2022/08/23Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
CYHB2201486Supplement2022/08/23Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Rupatadine Fumarate Tablets 1 records · Latest accepted 2022/08/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250471Supplement2022/08/01Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
二甲双胍格列吡嗪片 · No verified English name 1 records · Latest accepted 2022/05/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250283Supplement2022/05/24Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Olopatadine Hydrochloride Tablets 1 records · Latest accepted 2022/04/19

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2200643Supplement2022/04/19Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Olopatadine Hydrochloride Granules 1 records · Latest accepted 2021/12/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2102147Generic2021/12/06Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
二甲双胍格列吡嗪片(II) · No verified English name 1 records · Latest accepted 2021/09/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150894Supplement2021/09/29Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 3 applications

  1. 2026/10/13Accepted

    Cetylpyridinium Chloride Buccal Tablets

    CYHS2602521

    Fact date: 2026/10/13 · Date added to this site: 2026/10/22

    View source ↗
  2. 2026/09/23Accepted

    感冒清解颗粒 · No verified English name

    CYZB2604923

    Fact date: 2026/09/23 · Date added to this site: 2026/10/22

    View source ↗
  3. 2026/08/24Accepted

    杏灵分散片 · No verified English name

    CYZB2604298

    Fact date: 2026/08/24 · Date added to this site: 2026/10/22

    View source ↗

Under review

8 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Cetylpyridinium Chloride Buccal Tablets CYHS2602521Generic2026/10/13Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
感冒清解颗粒 · No verified English name CYZB2604923Supplement2026/09/23Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
杏灵分散片 · No verified English name CYZB2604298Supplement2026/08/24Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
Fexofenadine Hydrochloride Tablets CYHS2601983Generic2026/08/12Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
Fexofenadine Hydrochloride Tablets CYHS2601982Generic2026/08/12Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanizedCDE ↗
Lornoxicam for Injection CYHS2503203Generic2025/08/30Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) CYHS2501603Generic2025/04/29Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) CYHS2501602Generic2025/04/29Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

21 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Piracetam InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202656042026/08/04Generic approved under the new chemical-drug registration classificationCDE ↗
Fluvastatin Sodium Extended Release TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202654242026/07/28Generic approved under the new chemical-drug registration classificationCDE ↗
Azithromycin for SuspensionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202634382026/02/25Generic approved under the new chemical-drug registration classificationCDE ↗
Bosentan TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202690022026/01/05Generic approved under the new chemical-drug registration classificationCDE ↗
Pentoxifylline InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202630472026/01/05Generic approved under the new chemical-drug registration classificationCDE ↗
Piracetam InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202630202026/01/05Generic approved under the new chemical-drug registration classificationCDE ↗
依巴斯汀片 · No verified English nameBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202561472025/12/03Generic approved under the new chemical-drug registration classificationCDE ↗
Omeprazole Sodium for InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H200593182025/09/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Nicorandil TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202548122025/07/08Generic approved under the new chemical-drug registration classificationCDE ↗
Nicorandil for InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202472832024/11/12Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Bosentan TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202491402024/10/22Generic approved under the new chemical-drug registration classificationCDE ↗
Mitiglinide Calcium TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201531662024/05/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Mitiglinide Calcium TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202470072024/01/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Olopatadine Hydrochloride GranulesBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202342982023/10/18Generic approved under the new chemical-drug registration classificationCDE ↗
Rupatadine Fumarate TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201400972023/09/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Nicorandil for InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201200692023/07/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Nicorandil for InjectionBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201200702023/07/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
二甲双胍格列吡嗪片 · No verified English nameBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201400282023/05/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Olopatadine Hydrochloride TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202370312023/03/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
二甲双胍格列吡嗪片(II) · No verified English nameBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H201400292022/10/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Felodipine Sustained Release TabletsBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Beijing Sihuan Kebao Pharmaceutical Co., Ltd.国药准字H202231102022/03/08Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

2 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
盐酸贝凡洛尔 · No verified English nameBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Y20190008863A2023/03/24CDE ↗
硫辛酸 · No verified English nameBeijing Sihuan Kebao Pharmaceutical Co., Ltd.Y20190004123A2023/03/24CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

16 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Indobufen Tablets CYHB2600780Supplement2026/04/18Beijing Jia Lin Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
二甲双胍格列吡嗪片 · No verified English name CYHB2501345Supplement2025/07/09Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
二甲双胍格列吡嗪片(II) · No verified English name CYHB2302808Supplement2023/12/30Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
二甲双胍格列吡嗪片 · No verified English name CYHB2302807Supplement2023/12/30Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
注射用硝酸异山梨酯 · No verified English name CYHB2302770Supplement2023/12/26Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
注射用硝酸异山梨酯 · No verified English name CYHB2302769Supplement2023/12/26Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
注射用硝酸异山梨酯 · No verified English name CYHB2302768Supplement2023/12/26Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets CYHB2302311Supplement2023/10/18Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets CYHB2302310Supplement2023/10/18Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanizedCDE ↗
Indobufen Tablets CYHS2302426Generic2023/09/09Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Ozagrel Sodium Injection CYHS2300985Generic2023/04/06Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Ozagrel Sodium Injection CYHS2300984Generic2023/04/06Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Citicoline Sodium Injection CYHS2300904Generic2023/03/27Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Citicoline Sodium Injection CYHS2300903Generic2023/03/27Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Granisetron Hydrochloride injection CYHS2300812Generic2023/03/17Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗
Cetirizine Hydrochloride Injection CYHS2201895Generic2022/11/05Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.